Orchid Pharma (BOM:524372) Change In Receivables : ₹0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Orchid Pharma Change In Receivables?

Orchid Pharma's change in receivables for the quarter that ended in Sep. 2024 was ₹0 Mil. It means Orchid Pharma's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Orchid Pharma's change in receivables for the fiscal year that ended in Mar. 2024 was ₹196 Mil. It means Orchid Pharma's Accounts Receivable declined by ₹196 Mil from Mar. 2023 to Mar. 2024 .

Orchid Pharma's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹2,152 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Orchid Pharma's Days Sales Outstanding for the three months ended in Sep. 2024 was 88.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Orchid Pharma's liquidation value for the three months ended in Sep. 2024 was ₹1,587 Mil.

Orchid Pharma Change In Receivables Historical Data

The historical data trend for Orchid Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Change In Receivables Chart

Orchid Pharma Annual Data

Trend

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

440.11

-820.25

-229.19

-416.54

196.47

Orchid Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Orchid Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Orchid Pharma (BOM:524372) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Orchid Pharma's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2151.993	/	2226.986	*	91
=	88.18

2. In Ben Graham's calculation of liquidation value, Orchid Pharma's accounts receivable are only considered to be worth 75% of book value:

Orchid Pharma's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2479.426	-	4109.009	+	0.75 * 2151.993	+	0.5 * 3205.788
=	1,587

Orchid Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (BOM:524372) » Definitions » Change In Receivables

Traded in Other Exchanges

ORCHPHARMA:India

Address

Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines